Net Cash Provided by (Used in) Operating Activities |
720M |
USD |
-6.62% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
900M |
USD |
|
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-878M |
USD |
-206% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
5B |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
1.26B |
shares |
+0.24% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
777M |
USD |
+247% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
1.71B |
USD |
+89.8% |
Q2 2025 |
Q2 2025 |
Payments to Acquire Property, Plant, and Equipment |
238M |
USD |
-19% |
Q1 2025 |
Q1 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-4.85B |
USD |
-367% |
Q2 2025 |
Q2 2025 |
Deferred Income Tax Expense (Benefit) |
51M |
USD |
+5000% |
Q1 2025 |
Q1 2025 |
Additional Paid in Capital |
52.2B |
USD |
+0.21% |
Q2 2025 |
Q2 2025 |
Amortization of Intangible Assets |
246M |
USD |
-3.15% |
Q2 2025 |
Q2 2025 |
Depreciation, Depletion and Amortization |
241M |
USD |
+0.84% |
Q2 2025 |
Q2 2025 |
Interest Expense |
926M |
USD |
+1.54% |
Q2 2025 |
Q2 2025 |